Cystatin C versus creatinine for kidney function-based risk [6]

New England Journal of Medicine

Volumn 369, Issue 25, 2013, Pages 2458-2459

  Vandecasteele, Stefaan J ^a   De Vriese, An S ^a  

^a Sint Jan General Hospital   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; CREATININE;

END STAGE RENAL DISEASE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; PATIENT CARE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; BLOOD; CHRONIC KIDNEY FAILURE; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; NOTE;

CREATININE; CYSTATIN C; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84890354367     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1312801     Document Type: Letter

References (4)

1. Hallan SI, Orth SR. The KDOQI 2002 classification of chronic kidney disease: for whom the bell tolls. Nephrol Dial Transplant 2010;25:2832-6.
2. Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010;363:609-19.
3. Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009;361:1539-47.
4. Reuben DB, Tinetti ME. Goal-oriented patient care - an alternative health outcomes paradigm. N Engl J Med 2012;366:777-9.